Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    64,481.56
    +961.25 (+1.51%)
     

  • CMC Crypto 200

    1,386.36
    +73.73 (+5.96%)
     

  • S&P 500

    4,991.63
    -19.49 (-0.39%)
     

  • Dow

    37,955.17
    +179.79 (+0.48%)
     

  • Nasdaq

    15,423.67
    -177.83 (-1.14%)
     

  • Gold

    2,406.10
    +8.10 (+0.34%)
     

  • Crude Oil

    82.87
    +0.14 (+0.17%)
     

  • 10-Yr Bond

    4.6040
    -0.0430 (-0.92%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Should Pfizer Be Your Next Coronavirus Buy?

Cory Renauer, The Motley Fool
·5-min read
Should Pfizer Be Your Next Coronavirus Buy?

The coronavirus pandemic has the world's drugmakers working together to deliver medical solutions and some companies are poised to contribute more than others. With a coronavirus vaccine candidate in late-stage clinical trials and a contract to help manufacture the only COVID-19 antiviral treatment available at the moment, Pfizer (NYSE: PFE) is contributing more than the vast majority of its big pharma peers. Do Pfizer's contributions to the fight against the COVID-19 pandemic make it a good stock to buy right now?

Continue reading